Key highlights: Once-daily oral administration No food or water restrictions No injections required ~12% mean weight loss in Phase 3 trials Improvements in cardiometabolic risk markers Indication: Approved for adults with obesity, or overweight individuals with weight-related comorbidities, alongside reduced-calorie diet and increased physical activity
Chen K, Zhu Y, Zhang Y, Hamza T, Yu H, Fleur AS et al (2020) A probiotic yeast-based immunotherapy against Clostridioides difficile infection
By fostering motivation and connection, providers can enhance adherence, improve outcomes, and build long-term patient trust
Due to this move, the WHO is recognizing the benefits of GLP-1 receptor agonists beyond just the management of blood glucose in type 2 diabetes but extending their recognition of their benefits on body weight and adiposity, heart, and kidney outcomes in high-risk type 2 diabetes, said Reichelt
Table of Contents B12 vs